The KCNK3 Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population, specifically designed for targeted disruption of the KCNK3 gene in HeLa cells. This polyclonal pool provides a heterogeneous loss-of-function model for investigating the TASK-1 potassium channel??s influence on resting membrane potential, cellular excitability, and downstream signaling networks. By preserving diverse editing events, the population better mirrors heterogeneous knockout effects, making it a versatile tool for functional assays in cancer biology and ion channel research.
The host HeLa cell line is a human cervical adenocarcinoma model, characterized by HPV18 integration and expression of the E6 oncoprotein, which targets p53 for ubiquitin-mediated degradation, while maintaining high telomerase activity for sustained proliferation. This immortalized, epithelial-like line exhibits genomic instability and robust growth, facilitating CRISPR/Cas9 editing and downstream phenotypic analyses. Its widespread use in cancer research provides a well-characterized background for studying KCNK3 function.
KCNK3 encodes TASK-1, a two-pore domain potassium channel that mediates leak K+ currents to set the resting membrane potential. The channel is regulated by multiple upstream signals: G??q/11-coupled receptors (endothelin and angiotensin receptors) inhibit TASK-1 via PIP2 depletion; PKA, activated by cAMP, also modulates channel gating; HIF-1?? links to hypoxia-driven regulation; and extracellular pH directly tunes activity. TASK-1 forms functional heterodimers with KCNK9 (TASK-3) and interacts with 14-3-3 proteins and PIP2. Knockout depolarizes the membrane, impacting calcium signaling, cell cycle progression, and apoptosis. Core pathway components include cAMP, PKA, PIP2, and HIF-1??, integrating metabolic and stress signals.
In the HeLa cellular context, KCNK3 ablation abolishes TASK-1-mediated background K+ conductance, leading to membrane depolarization and disrupted calcium homeostasis. These alterations can modulate calcium-dependent pathways, potentially affecting proliferation and apoptotic resistance. The p53-deficient and telomerase-positive background of HeLa cells allows investigation of how TASK-1 dysfunction interacts with oncogenic processes, highlighting the channel??s role in cancer cell physiology.
This polyclonal knockout model is suited for electrophysiological characterization using whole-cell patch clamp to assess membrane conductance changes. Fluorometric assays (e.g., FLIPR) and calcium imaging enable quantification of depolarization and Ca2+ transient alterations. Standard molecular techniques like western blotting and RT-qPCR verify KCNK3 disruption, while MTS and Annexin V assays connect channel loss to proliferation and apoptosis. The cells also facilitate screening for pharmacological modulators and examining crosstalk between hypoxia signaling and GPCR pathways. For inquiries, please contact Ascent Research.
